FDABridge
← Zurück zum Blog
FDA-Fallbeispiele

FDA Stories #025 — EU Safety Gate Shows Why CPNP Notification Is Not Product Approval

Europe's 2025 Safety Gate data put cosmetics first among dangerous-product alerts, showing why a CPNP notification number never replaces full EU compliance.

FDABridge-Team19. Aug. 20264 Min. Lesezeit

Short answer: CPNP is a mandatory EU notification system, not a cosmetic product approval. A notification reference confirms that information was submitted; it does not prove that the formula, safety assessment, Product Information File, claims, manufacturing, or label complies with Regulation (EC) No 1223/2009.

This CPNP story summarizes public European Commission data rather than an FDABridge client matter. It is included in the FDA Stories series because many exporters manage US MoCRA and EU CPNP obligations together.

What did the 2025 EU Safety Gate report show?

The European Commission reported 4,671 Safety Gate alerts in 2025, the highest annual total since the system began in 2003. Cosmetics represented 36 percent of dangerous-product alerts — more than any other product category. National authorities also recorded 5,794 follow-up actions, including border stops, market withdrawals, online-listing removals, and consumer recalls.

According to the Commission, almost eight in ten cosmetic alerts concerned BMHCA, also known as Lilial, a banned synthetic fragrance ingredient associated with reproductive harm and skin irritation. The data show the difference between submitting product information and maintaining legal compliance throughout a product's commercial life.

What does CPNP notification actually do?

Article 13 of the EU Cosmetics Regulation requires the Responsible Person to notify defined product information electronically before placing the cosmetic on the EU market. CPNP makes that information available to competent authorities for market surveillance and to poison centres or similar bodies for medical treatment.

CPNP is therefore a notification and information-sharing portal. The European Commission does not pre-approve every submitted formula or label. National authorities can sample a notified product, inspect its file, identify a prohibited ingredient or labeling defect, and order corrective action after market entry.

What must exist before a valid CPNP notification?

  • An EU-established Responsible Person accepted in writing and shown correctly on the product label.
  • A Cosmetic Product Safety Report completed and signed by an appropriately qualified safety assessor.
  • A Product Information File containing the product description, CPSR, GMP statement, claim support, and required testing information.
  • A formula checked against the current prohibited, restricted, colorant, preservative, and UV-filter annexes.
  • EU-compliant labeling, including INCI ingredients, warnings, nominal content, batch identification, function, durability information, origin, and required local languages.
  • Manufacture under cosmetic good manufacturing practice and a post-market process for complaints and serious undesirable effects.

Why legacy formulas create CPNP risk

A formula may have been compliant when first notified and become noncompliant after an annex amendment or ingredient prohibition. A CPNP record does not update the formula, reformulate old inventory, revise labels, or refresh the CPSR automatically. The Responsible Person must monitor regulatory change and keep the compliance file current.

The 2025 BMHCA alerts illustrate the operational problem: old fragrance bases, artwork files, supplier specifications, or remaining stock can keep a prohibited ingredient in commerce after the rule changes. Portfolio control must connect each CPNP notification to the current formula version, supplier documentation, CPSR, label, and countries of sale.

Quick answers for non-EU cosmetic brands

Is a CPNP number an EU cosmetic certificate?

No. CPNP produces a notification reference, not an approval certificate or official finding that the cosmetic complies.

Does one CPNP notification cover all EU countries?

The central notification removes the need for a separate national product notification within the EU, but national language, labeling, distribution, tax, packaging, and market-surveillance obligations may still apply.

Who is legally accountable for the notified product?

The EU-established Responsible Person is responsible for ensuring compliance with the Cosmetics Regulation and for coordinating corrective action when a product is noncompliant.

Verified public sources

  • European Commission CPNP overview: https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-product-notification-portal_en
  • Regulation (EC) No 1223/2009, including Articles 10, 11, and 13: https://eur-lex.europa.eu/eli/reg/2009/1223/2024-04-04/eng
  • European Commission 2025 Safety Gate report summary: https://cyprus.representation.ec.europa.eu/news/commissions-2025-safety-gate-report-shows-increased-action-against-dangerous-products-and-stronger-2026-03-05_en

FDABridge supports non-EU cosmetic brands with Responsible Person service, CPSR and PIF coordination, label review, and CPNP notification. Visit fdabridge.com/eu-cosmetics or fdabridge.com/apply/eu-cosmetics.

Brauchen Sie als Nächstes Hilfe?

Vermeiden Sie diesen Fehler in Ihrem Unternehmen

Prüfen Sie Registrierung, Kennzeichnung und Importkette, bevor ein Fehler zu einer kostspieligen Zurückhaltung führt.

Weitere Beiträge

Verwandte Artikel

FDA-Fallbeispiele

FDA Stories #001 – Es dauerte acht Tage, bis ein sizilianisches Olivenöletikett an der US-Grenze zurückgewiesen wurde

16. Apr. 2026

Drei Generationen Olivenanbau. Preisgekröntes Öl. Ein wunderschönes Etikett. Und drei Verstöße gegen die Bundeskennzeichnung, die offensichtlich verborgen bleiben.

Weiterlesen →
FDA-Fallbeispiele

FDA Stories #002 – Eine vietnamesische Meeresfrüchtefabrik verlor ihre Registrierung und wusste 14 Monate lang nichts davon

24. Apr. 2026

Die Anlage exportierte seit sechs Jahren Garnelen in die USA. Dann wurde in Los Angeles ein Container festgehalten. Die FDA-Registrierung war abgelaufen – und niemand hat es ihnen gesagt.

Weiterlesen →
FDA-Fallbeispiele

FDA Stories #003 – Eine türkische Kosmetikmarke entdeckte, dass ihre Feuchtigkeitscreme ein nicht registriertes Medikament war

2. Mai 2026

Die Angabe „Lichtschutzfaktor 15“ auf ihrer meistverkauften Feuchtigkeitscreme bedeutete, dass es sich in den USA nicht um ein Kosmetikum handelte. Es war ein rezeptfreies Medikament. Sie hatten kein Arzneimittelregistrierung.

Weiterlesen →